Berlin, Germany

Dirk Scharn

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 7.9

ph-index = 3

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2010-2024

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dirk Scharn in Pharmaceutical Chemistry

Introduction

Dirk Scharn, an accomplished inventor located in Berlin, Germany, has made significant contributions to the field of pharmaceutical chemistry. With a remarkable portfolio comprising seven patents, his work primarily focuses on developing compounds that target various medical conditions, particularly oncological diseases.

Latest Patents

Dirk Scharn’s latest patents showcase innovative approaches to treating critical health issues. One notable invention involves substituted 1H-pyrazolo[4,3-c]pyridines and their derivatives as inhibitors of mutated epidermal growth factor receptor (EGFR), which are essential for treating and preventing oncological diseases. This invention comprises compounds characterized by specific groups as defined in the claims, affirming their potential use as effective medical treatments.

Another significant patent developed by Scharn centers around compounds for the inhibition of integrins. This invention pertains to a compound with a nonaromatic heterocyclic ring, designed to act as an antagonist of the fibronectin receptor alpha5beta1, serving as an anti-angiogenic agent. Such advancements highlight his commitment to addressing complex medical challenges.

Career Highlights

Dirk Scharn has had an impressive career, contributing his expertise to esteemed companies like Shire Orphan Therapies GmbH and Jerini AG. His roles within these organizations have undoubtedly facilitated the development of inventive solutions that bridge the gap between scientific research and real-world applications.

Collaborations

Throughout his career, Scharn has collaborated with notable professionals, including Gerd Hummel and Ulrich Reineke. These partnerships have fostered a creative environment that supports innovative thinking and the advancement of pharmaceutical technologies.

Conclusion

The inventive spirit of Dirk Scharn not only enhances the pharmaceutical landscape but also affirms the vital role of innovation in addressing pressing health challenges. By continually pushing the boundaries of research and development, he contributes to the ongoing quest for effective medical interventions, making his work both impactful and inspiring.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…